دورية
CD38 antibody re-treatment in daratumumab-refractory multiple myeloma after time on other therapies
| العنوان: | CD38 antibody re-treatment in daratumumab-refractory multiple myeloma after time on other therapies |
|---|---|
| المؤلفون: | Perez de Acha, Olivia, Reiman, Lauren, Jayabalan, David S., Walker, Zachary J., Bosma, Grace, Keller, Alana L., Parzych, Sarah E., Abbott, Diana, Idler, Beau M., Ribadeneyra, Drew, Niesvizky, Ruben, Forsberg, Peter A., Mark, Tomer M., Sherbenou, Daniel W. |
| المصدر: | Blood Advances; November 2023, Vol. 7 Issue: 21 p6430-6440, 11p |
| مستخلص: | •We show that patients gradually recover CD38 antibody sensitivity while on other treatments.•We conclude that re-treatment efficacy may improve by waiting 1 year before rechallenge and alternating anti-CD38 agents. |
| قاعدة البيانات: | Supplemental Index |
Full Text Finder | تدمد: | 24739529 24739537 |
|---|---|
| DOI: | 10.1182/bloodadvances.2023010162 |